SCHEMBL9309

SCHEMBL9309

COc1cc[c]cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27640435 0.98 RAB9A (0.36)
SCHEMBL28733761 0.98 RAB9A (0.36)
SCHEMBL23365328 0.83 HTR2A (0.39)
SCHEMBL8422 0.82
SCHEMBL27563324 0.80 TDP1 (0.36)
SCHEMBL8674 0.78 CA2 (0.46)
SCHEMBL28367075 0.78 TDP1 (0.33)
SCHEMBL161774 0.77 L3MBTL1 (0.46)
SCHEMBL542967 0.77 TRPV3 (0.31)
SCHEMBL21268193 0.77 L3MBTL1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3557 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118307569-A 2-Aryl-4-boron heterocyclic compound, and stereoselective preparation method and application thereof 武汉大学 2024-07-09 CN claimed
CN-118206551-A Quinoline compounds, their preparation and their use as antimalarial agents 美国卫生和人力服务部 2024-06-18 CN claimed
WO-2024115549-A1 ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-06 WO claimed
US-20240174603-A1 MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME RAPPTA THERAPEUTICS OY (FI) 2024-05-30 US claimed
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 US claimed
US-RE49934-E1 Inhibitors of cellular metabolic processes SERVIER PHARMACEUTICALS LLC (US) 2024-04-23 US claimed
EP-3893645-B1 SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2024-04-17 EP claimed
WO-2024073283-A1 HETEROCYCLES AS MODULATORS OF NSD ACTIVITY BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-04-04 WO claimed
WO-2024073282-A2 HETEROCYCLES AS MODULATORS OF NSD ACTIVITY BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-04-04 WO claimed
EP-4288412-A1 MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME Rappta Therapeutics Oy (FI) 2023-12-13 EP claimed
CN-1094613-A Novel therapeutic agents SMITHKLINE BEECHAM PLC (GB) 1994-11-09 CN claimed
EP-0619806-A1 PREPARATION OF SUBSTITUTED PIPERIDINES. PFIZER (US) 1994-10-19 EP claimed
US-5326781-A Benzylimidazole derivatives as anxiolytic agents and cognition activators SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1994-07-05 US claimed
WO-1994013656-A1 BICYCLIC COMPOUNDS WITH PHARMACEUTICAL ACTIVITY SMITHKLINE BEECHAM PLC (GB) 1994-06-23 WO claimed
US-5231105-A Ethylamine derivatives and antihypertensives containing the same AJINOMOTO CO., INC. (JP) 1993-07-27 US claimed
WO-1993011110-A1 PREPARATION OF SUBSTITUTED PIPERIDINES PFIZER INC. (US) 1993-06-10 WO claimed
EP-0527869-A1 BENZYLIMIDAZOLE DERIVATIVES AS ANXIOLYTIC AND NOOTROPIC AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1993-02-24 EP claimed
WO-1991016890-A1 BENZYLIMIDAZOLE DERIVATIVES AS ANXIOLYTIC AND NOOTROPIC AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1991-11-14 WO claimed
EP-0141909-A2 E-Triazolylpentenols, process for their preparation and biocides and plant growth regulators containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-05-22 EP claimed
EP-0134515-A1 Azolyl-propane nitriles, method for the preparation of these compounds and biocide agents containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-03-20 EP claimed